TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients ...

Hilliard, the HHS spokesperson, told SFGATE on Tuesday that, “Secretary [Robert F.] Kennedy [Jr.] expects the highest ethical ...

Investors have once again turned to Chinese pharmaceutical company Jiangsu Hengrui to create a new biotech startup, this time ...

Biotech firm Bio-Techne missed its first-quarter revenue estimates on Wednesday, hurt by sluggish demand for its products amid soft biotech funding environment in China.

A Cambridge biomedical research institute that launched less than two years ago with roughly $500 million in private funding ...

Tech trends 2030 are reshaping business. Learn how AI, quantum computing, biotech, and emerging tools will drive the business ...

Nvidia joins India’s $2 billion deep tech alliance to mentor AI and chip startups, expanding its role in the nation’s ...

Bionova Scientific announced Thursday it would bring 200 new jobs to The Woodlands over the next several years, bolstering ...

Novo Nordisk’s latest offer is more than 30% above what Pfizer initially agreed to pay for the obesity biotech Metsera, not ...

Ionis Pharmaceuticals, Inc. shows promise with new drug launches and a robust pipeline. Click here to read IONS stock ...

A biotech stock with strong FDA approval odds this November may see limited upside amid a full valuation and a pending lawsuit.